Insider · CIK 0001435618

Babler Martin

Reports to the SEC for 9 companies · REDWOOD CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001435618

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-23	MPLTMapLight Therapeutics, Inc.A Award	Director	AAward	+7,864 sh	—	—	7,864
2026-06-23	MPLTMapLight Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+29.8K sh	—	—	29,804
2026-06-09	PRLDPrelude Therapeutics Inc · Director Stock Option (Right to Buy)A Award	Director	AAward	+38K sh	—	—	38,000
2026-01-26	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Director, President, CEO and Chairman	AAward	+746K sh	—	—	745,875
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−56.4K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−67.7K sh	—	—	0
2025-07-29	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Director, President, CEO and Chairman	AAward	+662K sh	—	—	662,000
2025-07-29	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Director, President, CEO and Chairman	AAward	+150K sh	—	—	150,000
2025-06-12	PRLDPrelude Therapeutics Inc · Director Stock Option (Right to Buy)A Award	Director	AAward	+38K sh	—	—	38,000
2025-04-01	ALMSALUMIS INC.P Purchase	Director, President, CEO and Chairman	PPurchase	+15.7K sh	$6.44	+$101K	106,454
2025-02-18	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Director, President, CEO and Chairman	AAward	+523K sh	—	—	523,000
2025-02-03	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+56.4K sh	—	—	56,400
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President, CEO and Chairman	DDisposition to Issuer	−107K sh	—	—	0
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President, CEO and Chairman	DDisposition to Issuer	−381K sh	—	—	0
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Director, President, CEO and Chairman	AAward	+263K sh	—	—	263,101
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President, CEO and Chairman	DDisposition to Issuer	−263K sh	—	—	0
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Director, President, CEO and Chairman	AAward	+21.4K sh	—	—	21,390
2024-07-01	ALMSALUMIS INC.A Award	Director, President, CEO and Chairman	AAward	+90.8K sh	—	—	90,804
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Director, President, CEO and Chairman	AAward	+535K sh	—	—	534,759
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President, CEO and Chairman	DDisposition to Issuer	−535K sh	—	—	0
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Director, President, CEO and Chairman	AAward	+246K sh	—	—	245,989
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President, CEO and Chairman	DDisposition to Issuer	−21.4K sh	—	—	0
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President, CEO and Chairman	DDisposition to Issuer	−246K sh	—	—	0
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Director, President, CEO and Chairman	AAward	+107K sh	—	—	106,951
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Director, President, CEO and Chairman	AAward	+478K sh	—	—	478,288
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President, CEO and Chairman	DDisposition to Issuer	−478K sh	—	—	0
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President, CEO and Chairman	DDisposition to Issuer	−107K sh	—	—	0
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Director, President, CEO and Chairman	AAward	+241K sh	—	—	241,210
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President, CEO and Chairman	DDisposition to Issuer	−241K sh	—	—	0
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Director, President, CEO and Chairman	AAward	+381K sh	—	—	380,852
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Director, President, CEO and Chairman	AAward	+107K sh	—	—	107,028
2024-07-01	ALMSALUMIS INC.D Disposition to Issuer	Director, President, CEO and Chairman	DDisposition to Issuer	−90.8K sh	—	—	0
2024-06-27	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Director, President, CEO and Chairman	AAward	+21.4K sh	—	—	21,390
2024-06-14	PRLDPrelude Therapeutics Inc · Director Stock Option (Right to Buy)A Award	Director	AAward	+23.5K sh	—	—	23,500
2024-05-02	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+67.7K sh	—	—	67,700
2023-06-16	PRLDPrelude Therapeutics Inc · Director Stock Option (Right to Buy)A Award	Director	AAward	+23.5K sh	—	—	23,500
2023-06-08	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2022-06-17	PRLDPrelude Therapeutics Inc · Director Stock Option (Right to Buy)A Award	Director	AAward	+31.3K sh	—	—	31,293
2022-05-12	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2021-07-19	PRLDPrelude Therapeutics Inc · Employee Stock Option (Right to Buy)A Award	Director	AAward	+36.4K sh	—	—	36,400
2021-05-11	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2020-09-28	Principia Biopharma Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director, President, CEO	DDisposition to Issuer	−83K sh	—	—	0
2020-09-28	Principia Biopharma Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director, President, CEO	DDisposition to Issuer	−200K sh	—	—	0
2020-09-28	Principia Biopharma Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director, President, CEO	DDisposition to Issuer	−187K sh	—	—	0
2020-09-28	Principia Biopharma Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director, President, CEO	DDisposition to Issuer	−116K sh	—	—	0
2020-09-28	Principia Biopharma Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director, President, CEO	DDisposition to Issuer	−155K sh	—	—	0
2020-09-28	Principia Biopharma Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director, President, CEO	DDisposition to Issuer	−60.5K sh	—	—	0
2020-09-28	Principia Biopharma Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director, President, CEO	DDisposition to Issuer	−110K sh	—	—	0
2020-09-28	Principia Biopharma Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director, President, CEO	DDisposition to Issuer	−85.7K sh	—	—	0
2020-09-28	Principia Biopharma Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director, President, CEO	DDisposition to Issuer	−50.8K sh	—	—	0

Recent filings

Accepted (ET)
Jun 254
Babler Martin0001435618-26-000011
SEC(opens sec.gov)
Jun 104
Babler Martin0001435618-26-000006
SEC(opens sec.gov)
Jan 284
Babler Martin0001435618-26-000003
SEC(opens sec.gov)
Oct 304
Babler Martin0001193125-25-259040
SEC(opens sec.gov)
Jul 314
Babler Martin0001415889-25-020801
SEC(opens sec.gov)
Jun 134
Babler Martin0001562180-25-004786
SEC(opens sec.gov)
Apr 34
Babler Martin0001415889-25-010049
SEC(opens sec.gov)
Feb 204
Babler Martin0001415889-25-004936
SEC(opens sec.gov)
Feb 54
Babler Martin0000950170-25-014434
SEC(opens sec.gov)
Jul 14
Babler Martin0001415889-24-018589
SEC(opens sec.gov)

Companies

Address

C/O MAPLIGHT THERAPEUTICS, INC. 800 CHESAPEAKE DRIVE

REDWOOD CITY, CA, 94063